THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 1,339,000 Value ($000) $1,232 Avg Close — Range —
Q2 2021
Shares 3,039,000 Value ($000) $2,865 Avg Close — Range —
Q1 2021
Shares 3,039,000 Value ($000) $3,092 Avg Close — Range —
Q4 2020
Shares 4,539,000 Value ($000) $4,252 Avg Close — Range —
Q3 2020
Shares 2,989,000 Value ($000) $2,664 Avg Close — Range —
Q2 2020
Shares 3,304,000 Value ($000) $3,118 Avg Close — Range —
Q1 2020
Shares 2,354,000 Value ($000) $2,409 Avg Close — Range —
Q4 2019
Shares 4,544,000 Value ($000) $4,630 Avg Close — Range —
Q3 2019
Shares 3,094,000 Value ($000) $2,871 Avg Close — Range —
Q2 2019
Shares 4,644,000 Value ($000) $4,028 Avg Close — Range —
Q1 2019
Shares 5,144,000 Value ($000) $5,003 Avg Close — Range —
Q4 2018
Shares 4,000,000 Value ($000) $4,092 Avg Close — Range —
Q3 2018
Shares 5,528,000 Value ($000) $6,536 Avg Close — Range —
Q2 2018
Shares 6,348,000 Value ($000) $6,280 Avg Close — Range —
Q1 2018
Shares 200,000 Value ($000) $201 Avg Close — Range —
Q4 2017
Shares 200,000 Value ($000) $219 Avg Close — Range —
Q3 2017
Shares 3,000,000 Value ($000) $3,683 Avg Close — Range —
Q2 2017
Shares 3,000,000 Value ($000) $4,049 Avg Close — Range —